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ABSTRACT 
 
Edible seaweeds have historically been consumed by coastal populations across the 
globe. Today, seaweed is still part of the habitual diet in many Asian countries. Seaweed 
consumption also appears to be growing in popularity in Western cultures, due both to 
the influx of Asian cuisine as well as notional health benefits associated with 
consumption. Isolates of seaweeds (particularly viscous polysaccharides) are used in an 
increasing number of food applications in order to improve product acceptability and 
extend shelf-life.  
Epidemiological evidence suggests regular seaweed consumption may protect 
against a range of diseases of modernity. The addition of seaweed and seaweed isolates to 
foods has already shown potential to enhance satiety and reduce the postprandial 
absorption rates of glucose and lipids in acute human feeding studies, highlighting their 
potential use in the development of anti-obesity foods. As seaweeds and seaweed isolates 
have the potential to both benefit health and improve food acceptability, seaweeds and 
seaweed isolates offer exciting potential as ingredients in the development of new food 
products. 
This review will outline the evidence from human and experimental studies that 
suggests consumption of seaweeds and seaweed isolates may impact on health (both 
positively and negatively). Finally, this review will highlight current gaps in knowledge 
in this area and what future strategies should be adopted for maximising seaweed's 
potential food uses. 
 
 
 
1. INTRODUCTION  
 
Biologically, seaweeds are classified as macroalgae, with subclassification as brown 
(Phaeophyta), red (Rhodophyta) or green algae (Chlorophyta). Some examples of these 
edible algae are outlined in Table 1. The nutritional properties of these seaweeds are 
discussed earlier in this edition and reviewed elsewhere [1,2]. In 1994/95 over 2,000,000 
tonnes (dry weight) of seaweed was harvested [3]. Much of this may be consumed as whole 
seaweed products, while a large proportion is also used in the production of over 85,000 
tonnes of viscous polysaccharides for various food and industrial applications [4]. 
Historically, seaweed is a readily available food source that has been consumed by 
coastal communities likely since the dawn of time [15,16]. Seaweed is consumed habitually 
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in many countries in South-East Asia [17]. However, as a wholefood it is not considered a 
habitual component of the Western diet [2]. In the West, seaweed isolates (e.g. alginate from 
brown algae and agar or carrageenan from red algae) are typically used industrially [18]. 
Seaweed consumption has gained a measure of acceptance in some Westernised cultures such 
as Hawaii, California and Brazil, where there are large Japanese communities who have had a 
tangible influence on the local dietary practices [19,20]. Low consumer awareness regarding 
potential health benefits and a lack of previous experience of seaweed challenges its use in 
the daily diet [21]. 
 
Table 1. Examples of edible algae 
 
Subclassificaton Genus Common Name 
Brown algae (Phaeophyta) Alaria Kelp/ bladderlocks 
 Himanthalia/ Bifurcaria Sea spaghetti, fucales 
 Laminaria Kelp/ kombu/ kumbu/ sea tangle 
 Saccharina Sugar wrack 
 Undaria wakame 
 Ascophyllum Egg wrack 
 Fucus Bladder wrack, rockweed 
 Sargassum Mojaban/Indian brown seaweed 
 Hizikia Hijiki 
 Sargassum Sea holly 
 Dictyotales  
 Eisenia Arame 
Red algae (Rhodophyta) Rhodymenia/ Palmaria Dulse 
 Porphyra Nori/ haidai/ kim/ gim 
 Chondrus Irish moss/ carrigeen 
 Mastocarpus/ Gigartina Stackhouse, Guiry 
 Gracilaria  
 Asparagopsis Limu Kohu 
 Grateloupia  
Green algae (Chlorophyta) Ulvaria/ Enteromorpha Laver/sea lettuce/ sea grass/nori 
Adapted from [2,5,6]. Further details from [7-14]. 
 
 
 
2. SEAWEED AS A WHOLE FOOD 
 
Consumption of seaweed in Europe and North America is minimal at present [22]. While 
instruments within Japan and Korea have been developed to assess dietary intake of seaweed 
[23,24], consumption is so infrequent in most Western cultures that it is not considered within 
nationwide dietary intake assessment surveys. In the USA and Canada seaweed is cultivated 
in onshore tanks and the market for it is growing. In Ireland there is a renewed interest in 
seaweed that once formed part of the traditional diet. Recipe books promoting the use of 'sea 
vegetables' or 'marine vegetables' [25] in home cooking are becoming more popular. As 
consumer health and nutrition become more influential in the food industry, the use of 
seaweed as an ingredient is on the rise [25], and product development involving salads and 
wraps appears to be slowly evolving. 
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The rich mineral and trace element content of seaweed compared to terrestrial plant foods 
can however, impact negatively on its sensory characteristics [2]. As an ingredient of 
composite foods, it has been shown to be acceptable to consumers when baked into breads 
(Ascophyllum nodosum up to 5% w/w; Hall et al., 2010; Mahadevan and Fairclough, personal 
communication) and added to pasta (Wakame - Undaria pinnatafida - up to 10% w/w;[26]). 
Further from these applications, seaweed has been added to low fat meat products where it 
contributes to water retention and gel formation [27]. Collectively, these results suggest that 
seaweed may be successfully included as an ingredient in a number of food applications. As 
dried seaweed is high in dietary fibre, along with a range of other potentially bioactive 
components, this addition has the potential to enhance the nutritional quality of a product.  
Habitual consumption of seaweed may offer a nutritionally rich addition to the diet. 
However, micronutrient intakes in excess of the RNI could be of concern to nutritionists, 
particularly where bioavailability is high. 
 
 
3. WHOLE SEAWEED USE IN FOODS 
 
Whole seaweeds have been incorporated into a range of foods including meat, and bakery 
products. Fairclough and Williams (personal communication) have recently successfully 
incorporated Ascophyllum nodosum into sausages. This usage has also previously been 
reported with Laminaria japonica (sea tangle) powder [28]. Previous authors have included 
Himanthalia elongate (sea spaghetti), Undaria pinnatifida (Wakame) and Porphyra 
umbilicalis (Nori) in frankfurter type products (gel/emulsion meat systems [29] and H. 
elongate in frankfurters [27,30,31]. More recently, U. pinnatifida and H. elongate have been 
incorporated into beef patties and restructured poultry steaks, respectively [32,33]. Recent 
work has also resulted in the production of an acceptable wholemeal bread enriched with 
Ascophyllum nodosum [34]. Locally, our research group has also added Ascophyllum 
nodosum to pizza bases, cheese and frozen meat products. Prabhasankar and colleagues have 
incorporated Sargassum marginatum (Indian brown seaweed) and U. pinnatifida into pasta 
[26,35]. The previously published literature described above reports mixed success in terms 
of acceptability of whole seaweed-enriched food products. There may also be issues involved 
in the large-scale processing of whole seaweed-enriched foods. 
 
4. ANTIMICROBIAL PROPERTIES OF WHOLE SEAWEEDS 
 
The incorporation of seaweed into foods has also been shown to have a preservative 
effect, particularly with regards to Gram-negative bacteria (Gupta et al., 2010), reducing the 
need to add salt. The antimicrobial properties of seaweed extracts have been well documented 
over the years [36-39]. However, there would appear to be a lack of published information 
regarding the antimicrobial properties and preservative effects when seaweed as a 'whole 
food' is incorporated into a food matrix. Previous studies would suggest that the overall 
antimicrobial capacity of seaweeds appears to be linked to their antioxidant content [40]. 
Several studies have been undertaken at Sheffield Hallam University where seaweed 
(Ascophyllum nodosum, Seagreens®) as a dried whole-food has been incorporated into 
various products for example processed meat products and bread products. 
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Figure 1. Changes in Total Viable Count (TVC ∎) and coliform numbers (□) over shelf-life in frozen 
processed meat products containing seaweed (dashed line). Control product (no seaweed added) is 
shown by continuous line. 
 
 
Figure 2. Changes in the population of lactic acid bacteria (LAB) in meat products containing 
Seagreens
®
 (Ascophyllum nodosum). The dashed line represents the seaweed-enriched product, while 
the control product is denoted by a continuous line. 
Figure 1 shows that the 3% w/w dried seaweed added to this processed meat product 
results in an overall 0.3 log10 cfu/g reduction in the total viable count over the two month trial 
period; however, when looking at specific populations of micro-organisms, this antimicrobial 
activity is particularly effective against Gram negative micro-organisms such as coliforms 
(showing a 0.7 log10 reduction cfu per gram of product) which is to be expected since Gram 
negative micro-organisms have a thinner cell wall than Gram positive micro-organisms 
making them more susceptible to antimicrobial agents. However, there is a significant 
reduction in the Gram positive lactic acid bacteria (LAB) population over shelf-life (0.5 log10 
- see Figure 2). Other data suggest similar reductions in yeast and mould populations (data not 
shown). 
Interestingly when a methanolic extract of the seaweed is used in a typical antimicrobial 
susceptibility test then the trend is also mirrored with Gram positive organisms, on the whole, 
showing more susceptibility to the antimicrobial agent(s) contained within the seaweed; 
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especially Bacillus cereus and Staphylococcus aureus, which show the greatest sensitivity to 
the extracted agent (see Table 2). Listeria monocytogenes also shows a noticeable 
susceptibility to the extract although to a lesser extent than the organisms named above.  
 
Table 2. Antimicrobial effects of a methanolic extract  
from Seagreens
®
 (Ascophyllum nodosum) 
 
Micro-organism Sensitivity 
Bacillus cereus (NCTC 7464) +++ 
Staphylococcus aureus (NCTC 12981) +++ 
Listeria monocytogenes (NCTC 7973) ++ 
Bacillus subtilis (NCTC 10400) + 
Listeria innocua (NCTC 11288) - 
Enterococcus faecalis (NCTC 775) - 
E. coli (NCTC 12241) ± 
E. coli 0157 * (NCTC 12900) ± 
Pseudomonas fluorescens - 
Salmonella typhimurium (NCTC 12023) + 
+++ - zone of clearance ≥ 7.5mm, ++ - zone of clearance 2.5 - 7.5 mm, + - zone of clearance ≤ 2.5 mm, 
- - no discernible zone of clearance, ± - indeterminate zone of clearance. 
 
 
Figure 3. Mould growth at nine days post-production in wholemeal breads containing differing amounts 
of Seagreens®. Photograph A - control loaf with standard salt content. Photograph B - loaf containing a 
50:50 mix of added salt and Seagreens®. Photograph C - loaf with Seagreens® instead of added salt. 
When Seagreens® is incorporated into bakery products especially wholemeal bread as a 
replacement for salt (as sodium chloride) there is a suppression of mould growth for up to 9 
days in preservative-free bread when compared to preservative-free control bread containing 
5 g of salt (as sodium chloride) and no Seagreens®. Similar results have been recorded in all 
the other bread varieties baked at Sheffield Hallam University; with the exception of white 
bread where no significant suppression has been seen and mould growth occurs after 3 to 4 
days. Figure 3 shows wholemeal breads containing different amounts of Seagreens® at 9 
days.  
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5. COMPONENTS OF SEAWEEDS 
 
As previously stated, the use of seaweeds in Western diets is predominantly limited to 
use in food additives or extracts [41]. In line with other natural foods like fruits, vegetables 
and grains, there has been marked interest within the scientific community to assess which 
fractions of seaweeds may be linked to the historically observed health benefits. For the 
purpose of this review, these factors are considered under two relatively crude banners: 
seaweed phytochemicals and seaweed polysaccharides. Seaweed proteins have also 
previously been assessed for their nutritional value [42-47] but will not be discussed within 
this chapter. As with other foods that have historically been consumed whole (e.g. fruits, 
vegetables and grain products), it must also be noted that isolation of such bioactive 
components may allow the development of food products and/or supplements with potential 
health benefits. This should not however preclude a drive to increase population-wide 
consumption of the original whole foods. 
 
 
5.1. Seaweed Polysaccharides 
 
Each seaweed subclassification differs in the type of dietary fibres they contain. Brown 
seaweeds for example contain the dietary fibres alginates, fucans and laminarans; red 
seaweeds contain galactans, agar and carageenans; whereas green seaweeds contain soluble 
ulvans and other insoluble fractions such as cellulose.As with plant polysaccharides, non-
starch entities play a vital role in seaweed structure both at a microscopic and macroscopic 
level. The varying roles of these polysaccharides within the macroalgae structure should be 
considered when comparing these different types of polysaccharides.  
In alginates, the presence and arrangement of carboxyl groups on spans of 3 or more 
guluronic acid residues can act to interact with hydrogen ions and divalent cations 
(particularly calcium) to cause gelation [48]. This allows gelation in specific formulations at 
room temperature. The presence and position of sulphate ester groups in carrageenans and 
other seaweed polysaccharides also appears to affect their gelation and ability to interact with 
other factors in composite foods [49,50]. The physicochemical variations in these 
polysaccharides allow for a wide variety of applications within the food industry. 
Polysaccharides of different viscosities that react differently under various conditions of 
temperature, pH and food chemistry are important tools in the arsenal of food formulators in 
order produce products with increased acceptability. 
Seaweed polysaccharides are extensively used as thickening agents in sweet and savoury 
sauces and condiments [51-53]. A number of applications of seaweed polysaccharides are 
also utilised in order to stabilise food products against degradation, staling and heating or 
cooling/freezing. These applications also act to improve the consumer acceptability of such 
products, as well as extending the shelf-life. A further novel applications of seaweed 
polysaccharides in food manufacture are discussed elsewhere [54]. 
Seaweed polysaccharides are generally water-soluble and very hydrophilic. Their action 
as stabilizers within food oil-water emulsions is suggested to be a result of their ability to 
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precipitate/adsorb onto oil droplets and sterically stabilize emulsions against flocculation and 
coalescence [55,56].  
Previous studies have also suggested that seaweed polysaccharides may be used at fat 
replacers in a range of food applications. Where this is carried out, seaweed polysaccharides 
and other hydrocolloid thickening agents can be used to reduce or replace added fats within 
foods in order to produce an end-product with reduced total fat content, while still allowing 
for a product with improved moisture retention and consistency. This role is crucial in the 
development of low-fat products with high consumer acceptability. This use of seaweed 
polysaccharides has been shown to facilitate the production of low fat versions of meat-based, 
starch-based, fat-based and fruit/vegetable-based products [51,52,57-59]. 
High viscosity polysaccharides are likely to have detrimental effects both in terms of the 
manufacturing process and product acceptability. As with other types of viscous 
polysaccharides, low viscosity fractions of the indigestible carbohydrate material from 
seaweeds could be used to develop food products with higher fibre content. 
 
 
5.2. Seaweed Phytochemicals 
 
Seaweeds also contain a range of unique phytochemicals not present in terrestrial plants. 
As such, edible seaweeds may be the only relevant dietary source of some of these factors. A 
wide range of studies have described the high antioxidant capacity of a range of edible 
seaweeds [18,60-62]. This capacity is endowed by the presence of sulphated polysaccharides 
[63], polyphenolic compounds [64] and antioxidant enzymes [65]. Oxidative stress may play 
a key role in the development of cancers and cardiovascular disease [66]. Phytochemical-rich 
foods should clearly form part of a healthy balanced diet. However, the human body has a 
number of physiological, biochemical and enzymatic processes by which it can combat 
oxidative stress outside of dietary intake. The routes by which the wide variety of phenolic 
compounds enter the circulation is not well characterised, nor is the bioavailability and half-
life/distribution of such factors in the human body. Previous intervention studies where 
dietary antioxidant intake has increased have not evidenced a parallel change in the total 
antioxidant capacity of the body [67,68]. While this casts doubt on the benefit of increasing 
polyphenolic consumption from the perspective of reducing oxidative stress, it must be noted 
that such compounds may have other physiological effects. 
Previous studies in animal models and cell culture have suggested that seaweed 
phytochemicals have the potential to inhibit the progression of carcinoma formation [69,70]. 
In vitro studies have also suggested a potential for phenolic compounds from seaweeds to 
inhibit the action of digestive enzymes [71,72]. Such an action would be considered to have 
the potential to affect macronutrient uptake and act as a therapeutic agent to help combat 
metabolic diseases. Further from these findings, a recent study has suggested that a 
polyphenol-rich extract of Ecklonia stolonifera improved glycaemic control in a non-insulin 
dependent diabetic mouse model [73]. A similar effect was also noted in a chemically-
induced diabetic mouse model [74]. Anti-inflammatory properties of a phlorotannin-rich 
extract from Ecklonia cava have also been demonstrated in vitro [75]. 
The above experimental evidence highlights some interesting ways in which these 
phytochemical compounds isolated from seaweed could benefit health. Certainly there has 
been great interest from the pharmaceutical industry in the high-throughput analysis of 
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macroalgal compounds for the development of novel drugs [76-78]. The new, more stringent 
regulations on novel food ingredients within the EU is likely make the inclusion of specific 
seaweed phytochemicals as bioactives more problematic than whole seaweed or seaweed 
polysaccharides, both of which have been used historically within this context. This should 
not act as a barrier to research that characterises the physiological effects of this range of 
interesting compounds and potential therapeutic agents, however. 
 
 
6. SEAWEEDS AND HEALTH 
 
Previous studies on seaweed consumption in humans have centred in the areas of the 
world where reasonable amounts of seaweeds are habitually consumed (particularly South-
East Asia). The evidence detailed below outlines a variety of potential benefits to health, with 
much of the research in whole seaweeds either focussed around their impact on metabolic 
disease (associated with increased phytochemical and fibre intake) or breast cancer (linked to 
increased iodine consumption). Both of these topics are reviewed in detail elsewhere [79,80]. 
 
 
6.1. Experimental Studies 
 
Numerous researchers have studied the health benefits of seaweed incorporation in the 
diets of rats, particularly with reference to their effects on blood lipid profiles. Wong et al. 
(1999) examined the lipid changing effects of 4 types of seaweed (1 red, 1 green and 2 brown 
at 5% dry weight of feed) compared to a control group (cellulose) in 60 male Sprague Dawley 
rats. Comparisons were made between serum total cholesterol, HDL cholesterol, LDL 
cholesterol, triglycerides and hepatic cholesterol. The results suggested that the red algae 
Hypnea charoides had the greatest hypocholesterolaemic effect; however no significant 
reductions in cholesterol were seen between any of the seaweeds. On the contrary, 
Colpomenia sinuosa (a brown algae) induced a significant (p<0.05) increase in total serum 
cholesterol [81].  
Carvalho et al. (2009) showed that the total cholesterol levels of rats fed a 
hypercholesterolaemic diet increased significantly (p<0.05) when supplemented with 
cellulose as opposed to the green seaweed Ulva fasciata (24% dry weight seaweed meal). The 
seaweed containing diet was able to keep the total cholesterol at levels similar to baseline, 
leading the authors to suggest the incorporation of seaweed into the diet might be important in 
the reduction of total cholesterol [41].  
Bocanegra et al. (2009) conducted a study in groups of ten rats that were fed a diet 
containing a cholesterol raising agent with either a cellulose-wheat starch mix, Nori algae or 
Konbu algae (7% weight as freeze-dried material). Rats fed the Nori and cholesterol-raising 
diet had lower postprandial cholesterolaemia, and a more positive lipid profile with regards to 
HDL and LDL lipid fractions (p<0.05) when compared to the comparable Konbu diet [82]. 
These studies, among othersof similar design, hint towards the variability of the 
biological effects of different varieties of edible seaweeds. They also highlight the potential 
for cardiovascular health benefits in certain cases. As with most animal-based dietary 
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interventions, the amounts of seaweed incorporated in the diet are extremely high and do not 
bear resemblance to the amounts eaten within the human diet. 
 
 
6.2. Epidemiological Studies 
 
The lack of a dietary intake assessment tool alongside the likely exceedingly low intake 
of seaweeds at a population level means that observational data linking seaweed intake to 
reduced disease risk have only been collected in South East Asian populations. The most 
recent, accessible data are summarised in Table 4.  
Such data should be interpreted with caution, firstly as they do not necessarily represent a 
causal relationship between seaweed intake and health outcomes, but rather an association 
between the two factors. Also, different species of edible seaweeds appear to have different 
effects on disease risk. In a Korean case-controlled study, increasing frequency of Porphyra 
species consumption was associated with reduced risk of breast cancer, whereas Undaria 
pinnatifida consumption did not [15]. These results highlight the wide variability in the 
bioactive content of seaweed species. Even within a specific type of seaweed, previous 
research has suggested there are significant seasonal variations in nutritional content [83-85], 
which is likely to impact the biological effects of edible components. As outlined in the 
section below on the negative impact of seaweed intake, certain population groups may be at 
risk from global or national guidelines based on high seaweed consumption. 
However, these data suggest that achievable daily intakes of seaweed (equating to 
approximately 30 g of fresh seaweed [15,24,86] or 2 g of dry seaweed [15] a day) appear to 
reduce disease risk compared to the lowest (close to zero intake) percentiles of seaweed 
consumption. Such data are also routinely extrapolated to represent lifelong patterns that 
reduce a disease risk and are therefore a rational basis on which to develop prudent lifestyle 
choices across the whole life-course. 
 
 
6.3. Intervention Studies 
 
Relatively few human intervention studies have assessed the impact on seaweed 
consumption on risk factors for future disease. One previous study [91] has assessed the 
impact of seaweed consumption over a number of weeks on markers of cardiovascular 
disease risk. The physiological effects of seaweed supplementation were investigated in terms 
of effect on a number of markers of health, including blood glucose levels and blood lipid 
profiles in males and females with type II diabetes mellitus and a BMI of <35kg/m
2
. Dried 
brown seaweeds (sea tangle and sea mustard) incorporated into a pill were consumed 3 times 
a day for 4 weeks as a food supplement. Total daily consumption of seaweed was 48g. After 
random assignment to either the control group or the seaweed supplementation group, and the 
completion of the trial, fasting blood glucose levels (p<0.01) and 2 hour postprandial glucose 
levels (p<0.05) were significantly lower in the seaweed supplemented group. However, while 
serum concentrations of triglycerides decreased, and HDL cholesterol levels significantly 
increased (p<0.05), levels of total and LDL cholesterol were not affected by seaweed 
supplementation. Nutrient intake (% energy from macronutrients) was identical over the 4 
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weeks, but the study had a relatively small sample size (n= 20), and while there was a control 
group (n=11), the study did not have a cross over design. 
 
Table 4. Summary of recent observational studies relating to dietary  
seaweed intake and health 
 
Disease/health 
concern 
Study design Odds ratio (95% CI) of 
highest seaweed to lowest 
Reference 
Serum total 
cholesterol 
Retrospective study in the Japanese 
population with data from 1980 and 
1990 for > 7000 people. Data were 
adjusted for age, BMI and total 
energy intake. 
Not reported. No 
significant effect of 
seaweed consumption 
[87] 
Type II 
diabetes and 
prediabetes 
3,405 Korean individuals, aged 20 - 
65 y. Retrospective study. Adjusted 
for diet and lifestyle. 
0.66 (0.43-0.99) for 
men and 0.80 (0.51-
1.24) for women 
[24] 
Osteoporosis 214 Japanese elderly participants. 
Prospective study assessing 
calcaneus stiffness changes over 5 
years. No adjustment of data. 
0.22 (0.07-67) in all 
individuals 
[88]  
Obesity 3760 Japanese women aged 18-20 y. 
Cross-sectional study assessing 3 
different eating patterns. 
0.57 (0.37-0.87) for 
BMI >25.0a 
[89] 
Cardiovascular 
disease 
mortality 
40547 Japanese men and women 
aged 40-79 y. Prospective study over 
seven years of follow-up. Not 
adjusted. 
0.73 (0.59 -0.90)a [90]  
Allergic 
rhinosinusitis 
1002 pregnant Japanese women. 
Cross-sectional study. Data adjusted 
for lifestyle and risk factors. 
0.51 (0.30–0.87) [86] 
Breast cancer 
occurrence 
South Korean case-control study. 
362 cases (30-65y) with controls 
matched for age and menopausal 
status. Data adjusted for 
multivitamin supplement use, 
number of children, breastfeeding, 
dietary factors, education, exercise, 
oral contraceptive use. 
0.48 (0.27-0.86)  [15] 
a
Seaweed was included as part of a healthy/traditional Japanese eating pattern (i.e. high intakes of 
vegetables, mushrooms, seaweeds, potatoes, fish and shellfish, soy products, processed fish, fruit 
and salted vegetables) and was not assessed independently. 
 
The amount of seaweed consumed within this intervention was very high compared to the 
amounts consumed in the observational studies above that appeared to have a biological 
effect. As such, they may not be sustainable within the diet of individuals on a long-term 
basis if such an amount were not consumed in pill-form. Nonetheless, these findings warrant 
the development of further participant-based interventions involving long-term seaweed 
consumption and cardiovascular health. 
In a study with twelve healthy female volunteers of healthy BMI, inclusion of 3 g of Nori 
(in capsules) 15 minutes before eating significantly blunted the postprandial glycaemic rise 
 11 
elicited from consumption of a white bread meal (containing 50 g of starch) [92]. These 
results were not duplicated in a recent study where the impact of inclusion of Ascophyllum 
nodosum as an integral ingredient within bread, consumed within a composite meal, was 
compared to a standard seaweed-free meal [93]. 
Daily supplementation with seaweed (20 g of Laminaria japonica diluted in water or a 
beverage) was administered in combination with diet, exercise and behavioural therapy to 
female, Korean college students (19-24y) over 8 weeks. Pre-post test analysis showed there 
were significant improvements, consistent with recommendations for weight management, 
across a range of anthropometric measures. However, the lack of a control group prohibits the 
authors from attributing such effects to any particular aspect of the intervention. There were 
no significant changes in blood lipids during this time [94].  
Dietary supplementation with seaweed (5 g of Alaria esculenta in capsule form) 
consumption (Alaria esculenta (L.)) did not signficantly affect serum oestradiol 
concentrations in a recent randomised, placebo-ontrolled crossover trial in fifteen healthy, 
postmenopausal females [95] . However, it was noted in this study that there was a signficant 
inverse correlation between seaweed dosage (expressed in terms of mg/kg body weight) and 
serum oestrodiol concentrations. The same intervention also elicited a significant increase in 
circulating levels of thyroid-stimulating hormone [96]. It was calculated that c.75mg/kg of 
body weight of seaweed would need to be ingested to have this oestodiol lowering effect, 
which would equate to approximately 4 - 5 g/day of dry seaweed consumption for females 
weighing between 55 and 75 kg. These preliminary results highlight the potential for seaweed 
as an important dietary factor in the prevention of breast cancer.  
There is a growing body of evidence on the acute benefits of alginate consumption to 
health-related parameters. Alginates are widely researched due to their unusual gelling 
properties and relatively low viscosity, meaning that higher amounts can be incorporated in 
foods or beverages than other types of seaweed polysaccharide. Relevant food products could 
be used to deliver other types of seaweed polysaccharide in such studies. An example of this 
is the work of Panlasigui et al. (2004) in which carrageenan in a powdered form was 
incorporated into 4 food products common in the Philippines: a yeast bread, a corn pudding, 
fish balls and a gruel like product [97]. Following a two-week intervention with these 
products, participants had significant improvements to plasma concentrations of total and 
HDL cholesterol compared to the control group (no intervention).  
Hoad et al. (2004) investigated the gastric emptying rates of a strong gelling (high-G) and 
a weaker gelling (low-G) alginate meal compared to a guar-based meal and a control (without 
added fibre). In vitro characterisation of the gelling properties of both alginate meals showed 
the formation of intragastric „lumps‟ which were shown to be associated with feelings of 
fullness and a reduction in hunger in the strong-gelling alginate condition[98]. The authors 
purport that acid-gelling agents, such as alginates, may be useful for those aiming to adhere to 
a weight-reducing diet. 
To that end, Paxman and colleagues (2008) demonstrated the capacity for a strong-
gelling alginate formulation to restrict free-living energy intake compared to a commercially 
available control formulation. The 7% (134.8 kcal) reduction in reported daily energy intake 
was consistent with published guidelines for weight management [99]. Similar significant 
findings were reported previously in overweight and obese women [100]. Such effects may be 
explained by the potential for seaweed isolates, particularly alginate to enhance satiety [101].  
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The potentially satiating effects of seaweed isolates are by no means unaminously 
reported in the literature, however. Findings from a well-controlled intervention show an 
alginate and guar-based breakfast bar had no effect on energy and macronutrient intake when 
incorporated into the habitual diet over 5 days [102]. The breakfast bar was consumed daily 
for 5 days and food intake recorded on 3 randomly selected days, however the authors purport 
that poor intragastric gelation of the fibres may explain the lack of a treatment effect. 
Similarly, acute ad libitum food intake was reportedly unaltered after a meal replacer 
containing alginate (0.4% and 0.8%) compared to a meal replacer alone [103], though hunger 
was significantly reduced for several hours following the treatment.  
Numerous authors have reported beneficial effects of seaweed isolates on postprandial 
glycaemia. 5.0 g of sodium alginate, added to food significantly attenuated the postprandial 
glycaemic response in type 2 diabetics by 31% compared to the control meal [104]. Wolf et 
al. (2002) incoporated 1.5 g of sodium alginate into a 100 g liquid glucose-based preload 
along with an acid-soluble calcium source to produce an acid-induced viscosity complex. The 
authors reported a non-significant fall in peak glycaemia and a significant reduction in 
incremental change from baseline AUC in healthy, non-diabetic adults following ingestion of 
the acid-induced viscosity complex compared to a soluble fibre-based control [105]. Williams 
and colleagues (2004) investigated the glycaemic response to a novel induced viscosity fibre 
(IVF) "crispy bar" (including 5.5 g guar gum and 1.6 g sodium alginate) compared to an 
alginate free bar in healthy adults. Postprandial glycaemia was significantly reduced at 15, 30,
 
45, and 120 minutes. The positive iAUC was significantly reduced by 33% following the IVF 
“crispy bar” compared to the control [106]. Previous work suggested that the existing positive 
correlation between AUC glycaemia and body fat percentage (control condition) could be 
attenuated when an ionic gelling sodium alginate preload was ingested prior to a test lunch. 
This finding suggests the enhanced postprandial glycaemic response at higher body fat 
percentages could be normalised in response to alginate ingestion [107]. 
Effects on lipid uptake are less well-reported. In subjects with ileostomies, alginate added 
to a meal increased the ileal output of fatty acids [108]. Similar to the previously reported 
findings for postprandial glycaemia, Paxman and colleagues suggested that the existing 
positive correlation between AUC cholesterolaemia and body fat percentage was also 
eliminated by ingestion of an ionic gelling sodium alginate preload [107]. 
 
 
6.4. Potential Negative Effects of Seaweed or Seaweed Isolate Consumption 
 
In Japan and Korea seaweed (often added to soup) is ingested by lactating mothers who 
believe it to promote an adequate supply of breast milk. Iodine, found in high concentrations 
in seaweed, is transmissible from mother to infant through breast milk and this local practice 
has led to documented cases of neonatal iodine toxicity and consequent hypothroidism, with 
its associated negative clinical consequences [109]. Toxic blue-green algae species can grow 
on edible seaweed and have been noted in the literature to be the causative factor in a number 
of food poisoning occurrences [110]. 
Components of seaweed bind to adsorb heavy metals [111], meaning that seaweed is 
particularly prone to contamination from polluted water, and its consumption is a potential 
route of toxic heavy metals entering the body. However, a recent Korean study assessed that 
high seaweed consumption (8.5 g/day) would result in exposure of individuals to significantly 
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less than 10% of the toxic quantities of arsenic, mercury, lead and cadmium [112]. Associated 
with this is the action of alginates and other seaweed polysaccharides in binding divalent 
cations. This has led to a concern over whether their inclusion in the diet could affect the 
bioavailability of calcium, iron and some trace elements (reviewed in [113]). However, it 
would be likely that these cations would be absorbed in the large intestine as dietary fibre 
breaks down. There is no evidence that alginate inclusion in the diet drives micronutrient 
deficiency in the toxicity studies previously carried out. Carrageenan intake has been linked 
to breast cancer progression by in vitro studies, which have become somewhat magnified in 
the safety literature [114]. 
 
 
SUMMARY 
 
Seaweed is a foodstuff that has been historically consumed around the globe but is only 
consumed in appreciable amounts in certain areas of the world today. Seaweed 
polysaccharides have been used within the food industry in a wide number of important 
applications aimed at improving the sensory properties and shelf-life of food products. 
Previous research would suggest that incorporation of whole seaweeds and seaweed 
polysaccharides into foods is generally acceptable to the consumer. Seaweed or seaweed-
isolate enrichment may not only benefit the nutritional value of a food product, but may also 
benefit the product in terms of improving the shelf-life and in some cases actually improving 
the sensorial properties. 
While chemical analysis would suggest a number of nutritional benefits of seaweed 
consumption, there is a need for a more evidence relating dietary intake to health. Acute 
intervention studies would suggest alginate consumption could have long-term benefits to 
parameters of cardiovascular health and in appetite regulation. As with whole seaweeds, there 
is a need for long-term dietary intervention studies in this area. Design of intervention studies 
is crucial to their success. As such, nutrition or health researchers should collaborate early on 
with food technologists/food industry in order to design and develop suitably appealing 
products with these ingredients. 
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